{"id":"https://openalex.org/W4200280437","doi":"https://doi.org/10.1016/j.fertnstert.2021.11.013","title":"Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study","display_name":"Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study","publication_year":2021,"publication_date":"2021-12-08","ids":{"openalex":"https://openalex.org/W4200280437","doi":"https://doi.org/10.1016/j.fertnstert.2021.11.013","pmid":"https://pubmed.ncbi.nlm.nih.gov/34895700"},"language":"en","primary_location":{"id":"doi:10.1016/j.fertnstert.2021.11.013","doi":"https://doi.org/10.1016/j.fertnstert.2021.11.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.fertnstert.2021.11.013","pdf_url":null,"source":{"id":"https://openalex.org/S45445671","display_name":"Fertility and Sterility","issn_l":"0015-0282","issn":["0015-0282","1556-5653"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fertility and Sterility","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.fertnstert.2021.11.013","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033028239","display_name":"Tasuku Harada","orcid":"https://orcid.org/0000-0002-1492-7275","observed_orcids":["https://orcid.org/0000-0002-1492-7275","https://orcid.org/0000-0001-9873-9898"]},"institutions":[{"id":"https://openalex.org/I4588055","display_name":"Tottori University","ror":"https://ror.org/024yc3q36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4588055"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tasuku Harada","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan","institution_ids":["https://openalex.org/I4588055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035399792","display_name":"Yutaka Osuga","orcid":"https://orcid.org/0000-0002-6660-1066","observed_orcids":["https://orcid.org/0000-0002-6660-1066"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Osuga","raw_affiliation_strings":["Obstetrics and Gynecology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Obstetrics and Gynecology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054512864","display_name":"Yusuke Suzuki","orcid":"https://orcid.org/0000-0001-5601-6501","observed_orcids":["https://orcid.org/0000-0001-5601-6501","https://orcid.org/0009-0009-3964-3947"]},"institutions":[{"id":"https://openalex.org/I4210090259","display_name":"ASKA Pharmaceutical (Japan)","ror":"https://ror.org/0097kbr85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yusuke Suzuki","raw_affiliation_strings":["Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210090259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000689407","display_name":"Masaki Fujisawa","orcid":"https://orcid.org/0009-0008-7696-7011","observed_orcids":["https://orcid.org/0009-0008-7696-7011"]},"institutions":[{"id":"https://openalex.org/I4210090259","display_name":"ASKA Pharmaceutical (Japan)","ror":"https://ror.org/0097kbr85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki Fujisawa","raw_affiliation_strings":["Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210090259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058802055","display_name":"Motoko Fukui","orcid":"https://orcid.org/0000-0002-2028-881X","observed_orcids":["https://orcid.org/0000-0002-2028-881X"]},"institutions":[{"id":"https://openalex.org/I4210090259","display_name":"ASKA Pharmaceutical (Japan)","ror":"https://ror.org/0097kbr85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Motoko Fukui","raw_affiliation_strings":["Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan. Electronic address: fukui-m@aska-pharma.co.jp","Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-2028-881X","affiliations":[{"raw_affiliation_string":"Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan. Electronic address: fukui-m@aska-pharma.co.jp","institution_ids":["https://openalex.org/I4210090259"]},{"raw_affiliation_string":"Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210090259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020255729","display_name":"Jo Kitawaki","orcid":"https://orcid.org/0000-0002-4359-959X","observed_orcids":["https://orcid.org/0000-0002-4359-959X"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jo Kitawaki","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan","institution_ids":["https://openalex.org/I40677808"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058802055"],"corresponding_institution_ids":["https://openalex.org/I4210090259"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":5.7776,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.97652035,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"117","issue":"3","first_page":"583","last_page":"592"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10935","display_name":"Endometriosis Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10935","display_name":"Endometriosis Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12054","display_name":"Menstrual Health and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12096","display_name":"Ectopic Pregnancy Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relugolix","display_name":"relugolix","score":1.0},{"id":"https://openalex.org/keywords/leuprolide-acetate","display_name":"leuprolide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/endometriosis-associated-pain","display_name":"endometriosis-associated pain","score":0.9319999814033508},{"id":"https://openalex.org/keywords/gnrh-antagonist","display_name":"GnRH antagonist","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oral-gnrh-antagonist","display_name":"oral GnRH antagonist","score":0.5609999895095825},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8669999837875366},{"id":"https://openalex.org/keywords/pelvic-pain","display_name":"pelvic pain","score":0.7540000081062317},{"id":"https://openalex.org/keywords/endometrioma","display_name":"endometrioma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6029999852180481},{"id":"https://openalex.org/keywords/hot-flashes","display_name":"hot flashes","score":0.5809999704360962},{"id":"https://openalex.org/keywords/intermenstrual-bleeding","display_name":"metrorrhagia","score":0.9210000038146973},{"id":"https://openalex.org/keywords/menstrual-resumption","display_name":"menstrual resumption","score":0.4790000021457672},{"id":"https://openalex.org/keywords/japanese-women","display_name":"Japanese women","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2779093440","wikidata":"https://www.wikidata.org/wiki/Q907160","display_name":"Leuprorelin","level":5,"score":0.9440332055091858},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8659217357635498},{"id":"https://openalex.org/C2779522080","wikidata":"https://www.wikidata.org/wiki/Q205764","display_name":"Endometriosis","level":2,"score":0.8156054019927979},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.7768514752388},{"id":"https://openalex.org/C2780136519","wikidata":"https://www.wikidata.org/wiki/Q7161805","display_name":"Pelvic pain","level":2,"score":0.6098559498786926},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6000329256057739},{"id":"https://openalex.org/C2779448150","wikidata":"https://www.wikidata.org/wiki/Q1992452","display_name":"Triptorelin","level":5,"score":0.5821734666824341},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4614255726337433},{"id":"https://openalex.org/C2777886879","wikidata":"https://www.wikidata.org/wiki/Q16875676","display_name":"Hormone antagonist","level":4,"score":0.44299063086509705},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.42082318663597107},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.40966907143592834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3483549952507019},{"id":"https://openalex.org/C2778894405","wikidata":"https://www.wikidata.org/wiki/Q318896","display_name":"Gonadotropin-releasing hormone","level":4,"score":0.2770516276359558},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.25266778469085693},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.24746829271316528},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.19026753306388855},{"id":"https://openalex.org/C2778575703","wikidata":"https://www.wikidata.org/wiki/Q50265477","display_name":"Luteinizing hormone","level":3,"score":0.15994426608085632},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.15959900617599487},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004715","descriptor_name":"Endometriosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004715","descriptor_name":"Endometriosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004715","descriptor_name":"Endometriosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005300","descriptor_name":"Fertility Agents, Female","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006727","descriptor_name":"Hormone Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011966","descriptor_name":"Receptors, LHRH","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016729","descriptor_name":"Leuprolide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017699","descriptor_name":"Pelvic Pain","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D017699","descriptor_name":"Pelvic Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017699","descriptor_name":"Pelvic Pain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.fertnstert.2021.11.013","doi":"https://doi.org/10.1016/j.fertnstert.2021.11.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.fertnstert.2021.11.013","pdf_url":null,"source":{"id":"https://openalex.org/S45445671","display_name":"Fertility and Sterility","issn_l":"0015-0282","issn":["0015-0282","1556-5653"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fertility and Sterility","raw_type":"journal-article"},{"id":"pmid:34895700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34895700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fertility and sterility","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/j.fertnstert.2021.11.013","doi":"https://doi.org/10.1016/j.fertnstert.2021.11.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.fertnstert.2021.11.013","pdf_url":null,"source":{"id":"https://openalex.org/S45445671","display_name":"Fertility and Sterility","issn_l":"0015-0282","issn":["0015-0282","1556-5653"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fertility and Sterility","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1966028477","https://openalex.org/W1969971130","https://openalex.org/W2059290856","https://openalex.org/W2145383112","https://openalex.org/W2147856649","https://openalex.org/W2158134092","https://openalex.org/W2163315477","https://openalex.org/W2204545205","https://openalex.org/W2276856939","https://openalex.org/W2616333165","https://openalex.org/W2624382807","https://openalex.org/W2752637078","https://openalex.org/W2758777954","https://openalex.org/W2898392298","https://openalex.org/W2914196959","https://openalex.org/W2971722175","https://openalex.org/W2978453381","https://openalex.org/W3083548215","https://openalex.org/W3106937247","https://openalex.org/W4211081176"],"related_works":["https://openalex.org/W3083548215","https://openalex.org/W3174133102","https://openalex.org/W4283034363","https://openalex.org/W2618728314","https://openalex.org/W6958289247","https://openalex.org/W6901828003","https://openalex.org/W6902083664","https://openalex.org/W6939693345","https://openalex.org/W4407166387","https://openalex.org/W6939679861"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,60,77,102,105,120],"efficacy":[4],"and":[5,36,54,145,158],"safety":[6],"of":[7,14,65,84,122,135,175],"40-mg":[8],"relugolix":[9],"(REL)":[10],"compared":[11],"with":[12,19,43,132],"those":[13],"leuprorelin":[15],"(LEU)":[16],"in":[17,31,104,184],"women":[18,192],"endometriosis-associated":[20,170],"pain.":[21,57,172],"DESIGN:":[22],"Phase":[23],"3,":[24],"multicenter,":[25],"randomized,":[26],"double-blind,":[27],"double-dummy,":[28],"active-controlled":[29],"study":[30],"Japanese":[32],"patients.":[33],"SETTING:":[34],"Hospitals":[35],"clinics.":[37],"PATIENT(S):":[38],"Women":[39],"aged":[40],"\u226520":[41],"years":[42],"regular":[44],"menstrual":[45],"cycles":[46],"(25-38":[47],"days)":[48],"experiencing":[49],"endometriosis":[50],"or":[51,81],"ovarian":[52],"endometrioma":[53],"reporting":[55],"pelvic":[56,112,171],"INTERVENTION(S):":[58],"In":[59,76],"REL":[61,66,157],"group,":[62,79],"40":[63],"mg":[64,83],"was":[67,86,101,164],"orally":[68],"administered":[69],"once":[70],"a":[71,188],"day":[72],"for":[73,92,111,125,137,156,160,168,191],"24":[74,93],"weeks.":[75,94],"LEU":[78,85,167],"3.75":[80],"1.88":[82],"subcutaneously":[87],"injected":[88],"every":[89],"4":[90],"weeks":[91],"MAIN":[95],"OUTCOME":[96],"MEASURE(S):":[97],"The":[98],"primary":[99],"endpoint":[100],"change":[103],"maximum":[106],"visual":[107],"analog":[108],"scale":[109],"score":[110],"pain":[113],"from":[114,149],"baseline":[115],"until":[116],"28":[117],"days":[118],"before":[119],"end":[121],"treatment.":[123,198],"RESULT(S):":[124],"LEU.":[126,161],"Drug-related":[127],"treatment":[128,150],"emergent":[129,151],"adverse":[130,152],"events":[131,153],"an":[133],"incidence":[134],">10%":[136],"both":[138,176],"groups":[139],"were":[140,154,178],"hot":[141],"flush,":[142],"metrorrhagia,":[143],"headache,":[144],"genital":[146],"hemorrhage.":[147],"Discontinuations":[148],"2.9%":[155],"4.3%":[159],"CONCLUSION(S):":[162],"Relugolix":[163],"noninferior":[165],"to":[166,195],"treating":[169],"Safety":[173],"profiles":[174],"medications":[177],"comparable,":[179],"although":[180],"menses":[181],"returned":[182],"earlier":[183],"patients":[185],"taking":[186],"REL,":[187],"huge":[189],"benefit":[190],"who":[193],"plan":[194],"conceive":[196],"after":[197],"CLINICAL":[199],"TRIAL":[200],"REGISTRATION":[201],"NUMBER:":[202],"ClinicalTrials.gov:":[203],"NCT03931915.":[204]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-12-31T00:00:00"}